Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?-Reference-Cited by-同舟云学术

Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

Published:2022-02 Issue: Volume:61 Page:84-90
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Deluche Elise^ORCID,Lachatre Denis,Di Palma Mario,Simon Hélène,Tissot Valentin,Vansteene Damien^ORCID,Meingan Philippe,Mohebi Alexis,Lenczner Grégory,Pigneur Francois,Goldwasser Francois,Raynard Bruno

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference41 articles.

1. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women's Health initiative randomized clinical trials;Neuhouser;JAMA Oncol,2015

2. Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer;Trestini;Crit Rev Oncol Hematol,2018

3. Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer;Martel;Breast,2018

4. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab;Pizzuti;Cancer Biol Ther,2018

5. Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy;Gennari;Cancer Epidemiol Prev Biomark,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis;Clinical Nutrition;2024-08

2. Impact of breast cancer neoadjuvant chemotherapy on plasma and urine amino acid profile, plasma proteins and nitrogen metabolism;Scandinavian Journal of Clinical and Laboratory Investigation;2024-06-27

3. The Relationship Between Body Composition and Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients;Cureus;2024-05-26

4. Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors;Cancer Chemotherapy and Pharmacology;2024-03-04

5. Association between Sarcopenia and Survival in Patients Undergoing Gamma Knife Surgery for Brain Metastasis from Breast Cancer: A Retrospective Single-centre Cohort Study;Clinical Oncology;2024-02